A detailed history of Private Ocean, LLC transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Private Ocean, LLC holds 2 shares of REGN stock, worth $1,513. This represents 0.0% of its overall portfolio holdings.

Number of Shares
2
Holding current value
$1,513
% of portfolio
0.0%

Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 30, 2024

BUY
$883.2 - $1071.19 $1,766 - $2,142
2 New
2 $2,000
Q3 2021

Nov 09, 2021

SELL
$574.03 - $680.96 $12,628 - $14,981
-22 Closed
0 $0
Q2 2021

Aug 02, 2021

SELL
$472.8 - $558.54 $2,364 - $2,792
-5 Reduced 18.52%
22 $12,000
Q4 2020

Jan 29, 2021

BUY
$478.3 - $607.98 $2,391 - $3,039
5 Added 22.73%
27 $13,000
Q1 2020

May 06, 2020

BUY
$336.18 - $494.43 $7,395 - $10,877
22 New
22 $10,000
Q1 2018

May 11, 2018

SELL
$315.82 - $393.78 $1,579 - $1,968
-5 Closed
0 $0
Q4 2017

Feb 12, 2018

BUY
$358.63 - $469.95 $1,793 - $2,349
5
5 $2,000

Others Institutions Holding REGN

About REGENERON PHARMACEUTICALS, INC.


  • Ticker REGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,190,000
  • Market Cap $81.1B
  • Description
  • Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...
More about REGN
Track This Portfolio

Track Private Ocean, LLC Portfolio

Follow Private Ocean, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Private Ocean, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Private Ocean, LLC with notifications on news.